NCT/Study#
NA /
SY-2101-101
An Open-label Phase 1 Study to Evaluate Pharmacokinetics, Safety, and Tolerability of SY-2101 in Adult Patients with Acute Promyelocytic Leukemia
DISEASE GROUP:
Leukemia
current phase:
Phase I
STUDY STATUS:
Active
Location:
Hackensack, NJ
For More information:
Call 201-518-3587
